Minimal residual disease in acute leukemia 1986

by

Write The First Customer Review

Relapse of leukemia following successful remission-induction therapy remains a major obstacle in the treatment of patients with acute leukemia. Leukemia recurs most frequently in patients with acute myeloblastic leukemia (AML) and high risk acute lymphoblastic leukemia (ALL) following chemotherapy and less often in patients with low risk ALL and particularly in patient groups> submitted to allogeneic marrow transplantation. ' It is likely that the great majority of these recurrences originate from residual leukemic cells ...

Minimal Residual Disease in Acute Leukemia 1986 2011, Springer

ISBN-13: 9789401083980

Softcover Reprint of the Origi edition

Trade paperback

Select
Minimal Residual Disease in Acute Leukemia 1986 1986, Springer, Dordrecht, Netherlands

ISBN-13: 9780898387995

1986 edition

Hardcover

Select